# Enovis CORP (ENOV)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/enovis-corp/ JSON: https://steadybase.io/company/enovis-corp.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: Enovis CORP
- Ticker: ENOV (NYSE)
- SEC CIK: 0001420800
- Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Headquarters: Lewisville, TX
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: enovis.com
- LinkedIn: https://www.linkedin.com/company/enovis
- Next earnings date: Feb 4, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/0001420800-26-000012-index.html
- Operating income: -$1.1B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/0001420800-26-000012-index.html
- Net income: -$1.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/0001420800-26-000012-index.html
- SG&A: $1.1B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/0001420800-26-000012-index.html
- Employees: 7,802 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Shares outstanding: 57,694,806 as of Oct 30, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000054/0001420800-26-000054-index.html
- Auditor: Ernst & Young LLP, Philadelphia, Pennsylvania, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm

## Business

Enovis Corporation (the “Company”, “Enovis”, “we” or “us”) is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing, and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $2.2B | -$1.1B | -$1.2B | $1.1B |
| Dec 31, 2024 | $2.1B | -$775.7M | -$825.5M | $1.0B |
| Dec 31, 2023 | $1.7B | -$65.7M | -$33.3M | $830.3M |
| Dec 31, 2022 | $1.6B | -$71.2M | -$13.3M | $772.9M |
| Dec 31, 2021 | $1.4B | -$62.8M | $71.7M | $665.8M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/enovis-corp.json

## Officers and directors

- Damien McDonald, Chief Executive Officer. Source: Form 4 filed Sep 4, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526384027/0001193125-26-384027-index.htm
- Phillip Benjamin (Ben) Berry, SVP, Chief Financial Officer. Source: Form 4 filed May 14, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526224738/0001193125-26-224738-index.htm
- Phillip B. Berry, Senior Vice President and Chief Financial Officer. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Oliver Engert, Chief Administrative Officer. Source: Form 4 filed Sep 8, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526385615/0001193125-26-385615-index.htm
- Laura Lee Singleton, SVP, Chief HR Officer. Source: Form 3 filed Apr 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526151635/0001193125-26-151635-index.htm
- Bradley J. Tandy, SVP and Chief Legal Officer. Source: Form 4 filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526100842/0001193125-26-100842-index.htm
- John Kleckner, Principal Accounting Officer. Source: Form 4 filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526100846/0001193125-26-100846-index.htm
- Patricia A. Lang, SVP, Chief HR Officer. Source: Form 4 filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526100844/0001193125-26-100844-index.htm
- Patricia Lang, Senior Vice President and Chief Human Resources Officer. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Sharon L. Wienbar, Chair of the Board of Directors. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Louis Vogt, GROUP PRESIDENT, RECON. Source: Form 4 filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526100843/0001193125-26-100843-index.htm
- Terry D. Ross, GROUP PRESIDENT, P&R. Source: Form 4 filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000119312526100845/0001193125-26-100845-index.htm
- A. Clayton Perfall, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Angela S. Lalor, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Barbara Bodem, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Brady R. Shirley, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Liam J. Kelly, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Philip Okala, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Rajiv Vinnakota, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- Barbara W. Bodem, Board member (per proxy). Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm
- Matthew L. Trerotola, Named in proxy. Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm
- Philip A. Okala, Board member (per proxy). Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm
- Phillip “Ben” Berry, Named in proxy. Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm
- Sharon Wienbar, Board member (per proxy). Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm
- Terry Ross, Named in proxy. LinkedIn: https://linkedin.com/in/terrydross. Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000052/cfx-20261105.htm
- Sep 1, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315226040919/form8-k.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000032/cfx-20260806.htm
- May 19, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315226024438/form8-k.htm
- May 7, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000017/cfx-20260507.htm
- Feb 26, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000008/cfx-20260226.htm
- Jan 12, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315226001206/form8-k.htm
- Dec 15, 2025: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315225027738/form8-k.htm
- Dec 10, 2025: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315225027007/form8-k.htm
- Nov 14, 2025: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1420800/000149315225023418/form8-k.htm

## Insider trades (Form 4)

- Sep 4, 2026: Oliver Engert (Chief Administrative Officer) bought 2,660 shares, about $50,008. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526385615/0001193125-26-385615-index.htm
- Sep 4, 2026: Damien McDonald (Chief Executive Officer) bought 13,035 shares, about $249,620. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526384027/0001193125-26-384027-index.htm
- Sep 3, 2026: Oliver Engert (Chief Administrative Officer) bought 7,598 shares, about $149,971. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526384028/0001193125-26-384028-index.htm
- Jun 15, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $20,920. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526273151/0001193125-26-273151-index.htm
- Jun 11, 2026: Oliver Engert (Chief Administrative Officer) bought 1,200 shares, about $25,948. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526271546/0001193125-26-271546-index.htm
- Jun 10, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $23,000. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526268213/0001193125-26-268213-index.htm
- Jun 1, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $22,220. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526256111/0001193125-26-256111-index.htm
- Mar 13, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $23,740. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526108925/0001193125-26-108925-index.htm
- Mar 10, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $23,930. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526104643/0001193125-26-104643-index.htm
- Mar 9, 2026: Oliver Engert (Chief Administrative Officer) bought 1,750 shares, about $41,700. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526100803/0001193125-26-100803-index.htm
- Mar 4, 2026: Oliver Engert (Chief Administrative Officer) bought 1,250 shares, about $31,045. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526094576/0001193125-26-094576-index.htm
- Feb 27, 2026: Oliver Engert (Chief Administrative Officer) bought 1,000 shares, about $25,500. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312526089585/0001193125-26-089585-index.htm
- Nov 25, 2025: John Kleckner (Principal Accounting Officer) bought 2,468 shares, about $74,830. Source: https://www.sec.gov/Archives/edgar/data/1420800/000119312525302580/0001193125-25-302580-index.htm
- Sep 11, 2025: Damien McDonald (Chief Executive Officer) bought 6,457 shares, about $199,973. Source: https://www.sec.gov/Archives/edgar/data/1420800/000095017025114315/0000950170-25-114315-index.htm
- Aug 22, 2025: Bradley J. Tandy (SVP and Chief Legal Officer) bought 3,200 shares, about $100,512. Source: https://www.sec.gov/Archives/edgar/data/1420800/000135828325000004/0001358283-25-000004-index.htm

## What management said

- "Our third-quarter results reflect continued progress against our innovation-led strategy and the benefits of executing with greater alignment, accountability, and discipline" Damien McDonald, Chief Executive Officer of Enovis (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000052/q32026earningspressrelease.htm

## Latest filings

- 8-K filed Sep 1, 2026: https://www.sec.gov/Archives/edgar/data/1420800/000149315226040919/form8-k.htm
- 10-K filed Feb 26, 2026: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/cfx-20251231.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1420800/000142080026000035/cfx-20260703.htm
- DEF 14A filed Apr 6, 2026: https://www.sec.gov/Archives/edgar/data/1420800/000149315226015302/formdef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/